Wednesday 5 October 2016

08:00

Registration and refreshments

09:00

Chairman’s opening remarks: Diva Duong, Vice President Compliance EMEA-APAC, IMS Health

Mr Dario Ghoddousi
09:05

Transparency landscape in Europe: Implementation of EFPIA in Pharma presented by Dario Ghoddousi, Vice President of Product Management, IMS Health

Session led by: ims-health
Mr Peter Herrmann
09:45

Accountability and risk of the compliance programme

10:15

Speed networking

10:45

Morning refreshments

Ms Michaeline Daboul
12:00

New Standards for Enterprise Compliance Management presented by Michaeline Daboul, President and CEO, MMIS | MediSpend

Session led by: mmis-|-medispend
12:30

Lunch

Compliant marketing and sales
13:30

Understanding the new marketplace and compliance issues raised by changes

Ms Asli Kasabaligil, Head of Medical & Business Integrity, UCB Pharma
Transparency and reporting
14:00

Making the numbers talk! See what your spend data may be telling us?

Session led by: qordata
Transparency and reporting
15:00

How to collect consent, report etc overcoming hurdles to be able to create the disclosure report?

Mrs Anna Byrom, Associate Director, Compliance EUCA, Intercept Pharma
Transparency and reporting
15:30

Maintaining the disclosure reports and consent e.g. data is moving, consent withdrawals, disputes

Mr Laurence Scates, Transparency Programme Director, Astellas Pharma EMEA
16:00

Afternoon refreshments

16:30

Dissemination and exchange of scientific information – the line between promotion and scientific exchange

16:30

Managing consent to disclose and relationships with HCPs

16:30

Overcoming issues in running a global compliance program

16:30

Peer to Peer Roundtables

16:30

Transparency

Mr Laurence Scates, Transparency Programme Director, Astellas Pharma EMEA
17:30

Closing Remarks and Networking

last published: 03/Oct/16 16:05 GMT